Corrigendum: Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

Front Oncol. 2024 Apr 8:14:1377858. doi: 10.3389/fonc.2024.1377858. eCollection 2024.

Reem Altaf¹, Umair Ilyas², Anmei Ma^{3

4}, Meiqi Shi³

¹ Department of Pharmacy, Iqra University, Islamabad, Pakistan.
² Department of Pharmaceutics, Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.
³ Department of Medical Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
⁴ Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.

Abstract

[This corrects the article DOI: 10.3389/fonc.2023.1206768.].

Keywords: NSCLC; bioinformatics; differentially expressed genes; microarray; mutational analysis.